controversy about whether naproxen is safer in patients with heart disease than other NSAIDs

March 2014

You'll hear controversy about whether naproxen is safer in patients with heart disease than other NSAIDs.

All NSAIDs have a "black box" warning about increased CV risk. This was added almost a decade ago after the withdrawal of Vioxx.

But CV risk isn't necessarily equal between NSAIDs.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote